USP5 attenuates NLRP3 inflammasome activation by promoting autophagic degradation of NLRP3

References

• Lu A, Magupalli VG, Ruan J, et al. Unified polymerization mechanism for the assembly of ASC-dependent inflammasomes. Cell. 2014;156(6):1193–1206.
   PubMed Web of Science ®Google Scholar
• Skeldon AM, Faraj M, Saleh M. Caspases and inflammasomes in metabolic inflammation. Immunol Cell Biol. 2014;92(4):304–313.
   PubMed Web of Science ®Google Scholar
• Kang MJ, Jo SG, Kim DJ, et al. NLRP3 inflammasome mediates interleukin-1beta production in immune cells in response to Acinetobacter baumannii and contributes to pulmonary inflammation in mice. Immunology. 2017;150(4):495–505.
   PubMed Web of Science ®Google Scholar
• Deuteraiou K, Kitas G, Garyfallos A, et al. Novel insights into the role of inflammasomes in autoimmune and metabolic rheumatic diseases. Rheumatol Int. 2018;38(8):1345–1354.
   PubMed Web of Science ®Google Scholar
• Martinon F, Petrilli V, Mayor A, et al. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006;440(7081):237–241.
   PubMed Web of Science ®Google Scholar
• Van De Veerdonk FL, Netea MG, Dinarello CA, et al. Inflammasome activation and IL-1beta and IL-18 processing during infection. Trends Immunol. 2011;32(3):110–116.
   PubMed Web of Science ®Google Scholar
• Dowling JK, O’Neill LA. Biochemical regulation of the inflammasome. Crit Rev Biochem Mol Biol. 2012;47(5):424–443.
   PubMed Web of Science ®Google Scholar
• Vandanmagsar B, Youm YH, Ravussin A, et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med. 2011;17(2):179–188.
   PubMed Web of Science ®Google Scholar
• Youm YH, Grant RW, McCabe LR, et al. Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging. Cell Metab. 2013;18(4):519–532.
   PubMed Web of Science ®Google Scholar
• Heneka MT, Kummer MP, Latz E. Innate immune activation in neurodegenerative disease. Nat Rev Immunol. 2014;14(7):463–477.
   PubMed Web of Science ®Google Scholar
• Huai W, Zhao R, Song H, et al. Aryl hydrocarbon receptor negatively regulates NLRP3 inflammasome activity by inhibiting NLRP3 transcription. Nat Commun. 2014;5:4738.
   PubMed Web of Science ®Google Scholar
• Fernandes-Alnemri T, Kang S, Anderson C, et al. Cutting edge: TLR signaling licenses IRAK1 for rapid activation of the NLRP3 inflammasome. J Immunol. 2013;191(8):3995–3999.
   PubMed Web of Science ®Google Scholar
• Lopez-Castejon G. Control of the inflammasome by the ubiquitin system. FEBS J. 2019;287(281):211–226.
   Google Scholar
• Song H, Liu B, Huai W, et al. The E3 ubiquitin ligase TRIM31 attenuates NLRP3 inflammasome activation by promoting proteasomal degradation of NLRP3. Nat Commun. 2016;7:13727.
   PubMed Web of Science ®Google Scholar
• Spalinger MR, Lang S, Gottier C, et al. PTPN22 regulates NLRP3-mediated IL1B secretion in an autophagy-dependent manner. Autophagy. 2017;13(9):1590–1601.
   PubMed Web of Science ®Google Scholar
• Yan Y, Jiang W, Liu L, et al. Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome. Cell. 2015;160(1–2):62–73.
   PubMed Web of Science ®Google Scholar
• Py BDF, Kim M-S, Vakifahmetoglu-Norberg H, et al. Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity. Mol Cell. 2013;49(2):331–338.
   PubMed Web of Science ®Google Scholar
• Hasegawa H, Hsu A, Tinberg CE, et al. Single amino acid substitution in LC-CDR1 induces Russell body phenotype that attenuates cellular protein synthesis through eIF2alpha phosphorylation and thereby downregulates IgG secretion despite operational secretory pathway traffic. MAbs. 2017;9(5):854–873.
   PubMed Web of Science ®Google Scholar
• Flores-Bellver M, Bonet-Ponce L, Barcia JM, et al. Autophagy and mitochondrial alterations in human retinal pigment epithelial cells induced by ethanol: implications of 4-hydroxy-nonenal. Cell Death Dis. 2014;5:e1328.
   PubMed Web of Science ®Google Scholar
• Avvakumov GV, Walker JR, Xue S, et al. Two ZnF-UBP domains in isopeptidase T (USP5). Biochemistry. 2012;51(6):1188–1198.
   PubMed Web of Science ®Google Scholar
• Hoffman HM, Wanderer AA, Broide DH. Familial cold autoinflammatory syndrome: phenotype and genotype of an autosomal dominant periodic fever. J Allergy Clin Immunol. 2001;108(4):615–620.
   PubMed Web of Science ®Google Scholar
• Pehote G, Vij N. Autophagy augmentation to alleviate immune response dysfunction, and resolve respiratory and COVID-19 exacerbations. Cells. 2020;9:9.
   Web of Science ®Google Scholar
• Ye X, Zhou XJ, Zhang H. Exploring the role of Autophagy-Related Gene 5 (ATG5) yields important insights into autophagy in autoimmune/autoinflammatory diseases. Front Immunol. 2018;9:2334.
   PubMed Web of Science ®Google Scholar
• Xu X, Huang A, Cui X, et al. Ubiquitin specific peptidase 5 regulates colorectal cancer cell growth by stabilizing Tu translation elongation factor. Theranostics. 2019;9(14):4208–4220.
   PubMed Web of Science ®Google Scholar
• Han S, Lear TB, Jerome JA, et al. Lipopolysaccharide primes the NALP3 inflammasome by inhibiting its ubiquitination and degradation mediated by the SCFFBXL2 E3 ligase. J Biol Chem. 2015;290(29):18124–18133.
   PubMed Web of Science ®Google Scholar
• Kawashima A, Karasawa T, Tago K, et al. ARIH2 ubiquitinates NLRP3 and negatively regulates NLRP3 inflammasome activation in macrophages. J Immunol. 2017;199(10):3614–3622.
   PubMed Web of Science ®Google Scholar
• Wan P, Zhang Q, Liu W, et al. Cullin1 binds and promotes NLRP3 ubiquitination to repress systematic inflammasome activation. FASEB J. 2019;33(4):5793–5807.
   PubMed Web of Science ®Google Scholar
• Guarda G, Braun M, Staehli F, et al. Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity. 2011;34(2):213–223.
   PubMed Web of Science ®Google Scholar
• Jin J, Yu Q, Han C, et al. LRRFIP2 negatively regulates NLRP3 inflammasome activation in macrophages by promoting Flightless-I-mediated caspase-1 inhibition. Nat Commun. 2013;4:2075.
   PubMed Web of Science ®Google Scholar
• Martinon F, Agostini L, Meylan E, et al. Identification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin inflammasome. Curr Biol. 2004;14(21):1929–1934.
   PubMed Web of Science ®Google Scholar
• Li H, Nookala S, Re F. Aluminum hydroxide adjuvants activate caspase-1 and induce IL-1beta and IL-18 release. J Immunol. 2007;178(8):5271–5276.
   PubMed Web of Science ®Google Scholar
• Ruiz PA, Moron B, Becker HM, et al. Titanium dioxide nanoparticles exacerbate DSS-induced colitis: role of the NLRP3 inflammasome. Gut. 2017;66(7):1216–1224.
   PubMed Web of Science ®Google Scholar
• Stutz A, Kolbe CC, Stahl R, et al. NLRP3 inflammasome assembly is regulated by phosphorylation of the pyrin domain. J Exp Med. 2017;214(6):1725–1736.
   PubMed Web of Science ®Google Scholar
• Palazon-Riquelme P, Worboys JD, Green J, et al. USP7 and USP47 deubiquitinases regulate NLRP3 inflammasome activation. EMBO Rep. 2018;19:10.
   PubMed Web of Science ®Google Scholar
• Song H, Zhao C, Yu Z, et al. UAF1 deubiquitinase complexes facilitate NLRP3 inflammasome activation by promoting NLRP3 expression. Nat Commun. 2020;11(1):6042.
   PubMed Web of Science ®Google Scholar
• Liu T, Wang L, Liang P, et al. USP19 suppresses inflammation and promotes M2-like macrophage polarization by manipulating NLRP3 function via autophagy. Cell Mol Immunol. 2020. DOI:https://doi.org/10.1038/s41423-020-00567-7
   Google Scholar
• Vande Walle L, Van Opdenbosch N, Jacques P, et al. Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis. Nature. 2014;512(7512):69–73.
   PubMed Web of Science ®Google Scholar
• Nakajima S, Lan L, Wei L, et al. Ubiquitin-specific protease 5 is required for the efficient repair of DNA double-strand breaks. PLoS One. 2014;9(1):e84899.
   PubMed Web of Science ®Google Scholar
• Nostramo R, Varia SN, Zhang B, et al. The catalytic activity of the Ubp3 deubiquitinating protease is required for efficient stress granule assembly in Saccharomyces cerevisiae. Mol Cell Biol. 2016;36(1):173–183.
   PubMed Web of Science ®Google Scholar
• Dayal S, Sparks A, Jacob J, et al. Suppression of the deubiquitinating enzyme USP5 causes the accumulation of unanchored polyubiquitin and the activation of p53. J Biol Chem. 2009;284(8):5030–5041.
   PubMed Web of Science ®Google Scholar
• Liu Y, Wang WM, Zou LY, et al. Ubiquitin specific peptidase 5 mediates histidine-rich protein Hpn induced cell apoptosis in hepatocellular carcinoma through P14-P53 signaling. Proteomics. 2017;17:12.
   Web of Science ®Google Scholar
• Kim SY, Kwon SK, Lee SY, et al. Ubiquitin-specific peptidase 5 and ovarian tumor deubiquitinase 6A are differentially expressed in p53+/+ and p53−/- HCT116 cells. Int J Oncol. 2018;52(5):1705–1714.
   PubMed Web of Science ®Google Scholar
• Liu Q, Wu Y, Qin Y, et al. Broad and diverse mechanisms used by deubiquitinase family members in regulating the type I interferon signaling pathway during antiviral responses. Sci Adv. 2018;4(5):eaar2824.
   PubMed Web of Science ®Google Scholar
• Qian G, Zhu L, Huang C, et al. Ubiquitin specific protease 5 negatively regulates the IFNs-mediated antiviral activity via targeting SMURF1. Int Immunopharmacol. 2020;87:106763.
   PubMed Web of Science ®Google Scholar
• Du Y, Lin J, Zhang R, et al. Ubiquitin specific peptidase 5 promotes ovarian cancer cell proliferation through deubiquitinating HDAC2. Aging (Albany NY). 2019;11(21):9778–9793.
   PubMedGoogle Scholar
• Zhang Z, Gao W, Zhou L, et al. Repurposing brigatinib for the treatment of colorectal cancer based on inhibition of ER-phagy. Theranostics. 2019;9(17):4878–4892.
   PubMed Web of Science ®Google Scholar